Overall rank by patents
#12,914
Across all tracked assignees
USPTO PatentsView assignee record - 23 granted patents across 15 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS).
The verdict
Ergon holds 23 US patents across 15 technology areas, rank #12,914 of 50,000 tracked assignees.
Ergon Asphalt & Emulsions, Inc. has been granted 23 US utility patents between 2016 and 2025, placing Ergon Asphalt & Emulsions, Inc. at rank #12,914 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.3 claims per patent with primary concentration in C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS). As a US Corporation, Ergon Asphalt & Emulsions, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Ergon sits between Elite Electronic Material (zhongshan) Co., Ltd. (23 patents, rank #12,910) and FHE USA Llc (23 patents, rank #12,918) - the closest US assignees by grant volume. The composite Innovation Score of 44.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 16 grants, compared with 7 in the 2015–2019 window, a +129% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ergon Asphalt & Emulsions, Inc.'s 18.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ergon Asphalt & Emulsions, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Elite Electronic Material (Zhongshan) Co., Ltd.
23 patents
Elobau GmbH & Co. KG
23 patents
Enovate Medical, LLC
23 patents
Enveric Biosciences Canada Inc.
23 patents
Excelsior Medical Corporation
23 patents
FALTEC Co., Ltd.
23 patents
FEDERAL-MOGUL VALVETRAIN GMBH
23 patents
FHE USA LLC
23 patents
Ergon Asphalt & Emulsions, Inc.
23 patents
What this shows Ergon holds 23 patents at rank #12,914, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #12,914 in granted patent volume.
Other assignees with the most granted patents in Ergon's primary technology class.
Ergon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 8.7% |
| 2017 | 2 | 8.7% |
| 2019 | 3 | 13.0% |
| 2020 | 1 | 4.3% |
| 2021 | 3 | 13.0% |
| 2022 | 2 | 8.7% |
| 2023 | 4 | 17.4% |
| 2024 | 3 | 13.0% |
| 2025 | 3 | 13.0% |
Top 15 of 15 technology areas
Overall rank by patents
#12,914
Across all tracked assignees
44.2 out of 100
How to use this portfolio
Ergon's 23 grants land it in the top 26% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.